BAY 73-6691
Code | Size | Price |
---|
TAR-T10481L-50mg | 50mg | £791.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T10481L-100mg | 100mg | £1,267.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
BAY 73-6691 is an inhibitor of brain penetrant PDE9A.
CAS:
794568-92-6
Formula:
C15H12ClF3N4O
Molecular Weight:
356.73
Pathway:
Metabolism
Purity:
0.98
SMILES:
C[C@H](Cc1nc(=O)c2cnn(-c3ccccc3Cl)c2[nH]1)C(F)(F)F
Target:
PDE
References
1. Li J, et al. Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-? peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease. Brain Res. 2016 Jul 1;1642:327-335.